USE OF AGENTS THAT UPREGULATE CRYSTALLIN EXPRESSION IN THE RETINA AND OPTIC NERVE HEAD

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090048146A1
SERIAL NO

11963571

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods to treat and/or prevent optic nerve damage in a subject by administering a composition comprising a crystallin agonist.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALCON INCRUE LOUIS-D' AFFRY 6 FRIBOURG 1701

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Clark, Abot F Arlington, US 1 0
Johnson, Elaine C Portland, US 1 0
Morrison, John C Portland, US 13 181

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation